Humalog Mix 50/50 — Blue Cross Blue Shield of Alabama
To improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus or type 2 diabetes mellitus
Preferred products
- Fiasp
- NovoLog
- Insulin Aspart
- Novolin R
- ReliOn R
- Novolin N
- Novolin 70/30
- Insulin aspart protamine/insulin aspart
Initial criteria
- Non-preferred insulin agents will be approved when ONE of the following is met:
- BOTH of the following:
- • The requested agent is a rapid insulin
- AND
- • There is information that the patient is currently using an insulin pump that has an incompatibility with the preferred rapid insulin agent that is not expected to occur with the requested agent
- OR
- The request is for Humalog Mix 50/50 AND ONE of the following:
- • The patient is currently using Humalog Mix 50/50 AND the prescriber states the patient is at risk if switched to a different insulin
- OR
- • The patient has tried and had an inadequate response to a preferred insulin mix
- OR
- BOTH of the following:
- • The requested agent is a rapid, regular, mix, or NPH insulin
- AND
- ONE of the following:
- • The patient has an intolerance or hypersensitivity to the preferred insulin agents of the same type (rapid or regular, mix or NPH) that is not expected to occur with the requested agent
- OR
- • The patient has an FDA-labeled contraindication to the generic equivalent that is not expected to occur with the requested agent
- OR
- • There is information that the patient has a physical or a mental disability that would prevent them from using a preferred insulin agent
- OR
- • The patient is pregnant
Approval duration
12 months